Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...
Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.
No country has affected global solar panel supply chains more than the United States. Since the boom of solar in the early ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Honda and GM are phasing out fuel cell production at their U.S. joint venture FCSM. Instead, the Japanese company prefers to ...
With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results